Fed. Circ. Backs Sanofi In Prostate Cancer Drug Patent Fight
The Federal Circuit on Wednesday ruled that a district judge lacked authority to invalidate claims of a patent on Sanofi's prostate cancer drug Jevtana that the company had disclaimed, and that...To view the full article, register now.
Already a subscriber? Click here to view full article